Assembly Biosciences, Inc. ASMB NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

59/100

4/7 Pass

SharesGrow Intrinsic Value

Assembly Biosciences, Inc. (ASMB) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Zlotnick Adam avec 1,321,009 actions. Parmi les autres détenteurs notables GILEAD SCIENCES, INC. et Small Derek A.

Au cours des 12 derniers mois, les initiés ont effectué 17 transactions sur ASMB l'action — 14 achats (d'une valeur de $25.19M) et 3 ventes (d'une valeur de $8.14K). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.

ASMB Participations des Initiés

Principal Actionnaire

Zlotnick Adam

1,321,009 actions

Achats (12 mois)

$25.19M valeur

Ventes (12 mois)

$8.14K valeur

Activité de transactions (12 mois)

Acheter 82%

Vendre 18%

Principaux actionnaires initiés

#	Nom	Rôle	Actions détenues	Dernière déclaration	Taille relative
1	Zlotnick Adam	10 Percent Owner	1,321,009	2014-09-09	100%
2	Gilead Sciences, Inc.	10 Percent Owner	1,147,960	2025-10-03	87%
3	Small Derek A	Director	828,791	2020-01-03	63%
4	Schornstein Alexander	10 Percent Owner	720,137	2024-11-26	55%
5	Ellison Russell H	Director	533,333	2015-04-15	40%
6	Okazaki Jason A	CEO and President	111,916	2026-03-31	8%
7	Samar Michael P.	Chief Financial Officer	77,228	2022-07-26	6%
8	Russo Thomas Joseph	CFO	54,633	2021-04-02	4%
9	Delaney William E Iv	Chief Scientific Officer	45,642	2026-03-31	3%
10	White Nicole S	Chief Manufacturing Officer	37,674	2026-03-31	3%
11	Papkoff Jacqueline Sybil	SVP-CSO Microbiome	37,364	2020-12-15	3%
12	Cooper Graham K	See Remarks	35,000	2019-04-02	3%
13	Colonno Richard James	EVP & CSO, Virology Ops	34,000	2020-03-31	3%
14	Rowland Thomas Andrew	Chief Business Officer	30,000	2012-01-18	2%
15	Gaggar Anuj	Chief Medical Officer	28,000	2026-03-31	2%
16	Lopatin Uri A	Chief Medical Officer	27,500	2019-04-02	2%
17	Barrett David Jonathan	See Remarks	25,000	2017-03-31	2%
18	Stamm Luisa M	Chief Medical Officer	22,500	2022-03-31	2%
19	Dimarchi Richard D	Director	20,000	2022-05-27	2%
20	Holubiak Myron Z	Director	15,000	2021-05-24	1%

Transactions récentes (12 derniers mois)

Date	Nom	Rôle	Type	Actions	Prix	Valeur
2026-03-29	Gaggar Anuj	Chief Medical Officer	Attribution de RSU	26,000	-	-
2026-03-30	White Nicole S	Chief Manufacturing Officer	Vente Informative	9	$27.49	$247.41
2026-03-29	White Nicole S	Chief Manufacturing Officer	Attribution de RSU	26,000	-	-
2026-03-30	Bjorkquist Jeanette M	Pfo and Pao	Vente Informative	16	$27.49	$439.84
2026-03-29	Bjorkquist Jeanette M	Pfo and Pao	Attribution de RSU	6,500	-	-
2026-03-29	Delaney William E Iv	Chief Scientific Officer	Attribution de RSU	26,000	-	-
2026-03-29	Okazaki Jason A	CEO and President	Attribution de RSU	94,250	-	-
2025-08-08	Gilead Sciences, Inc.	10 Percent Owner	Achat Informatif	1,147,960	$21.60	$24.8M
2025-06-16	Bjorkquist Jeanette M	Pfo and Pao	Attribution de RSU	600	$17.24	$10.34K
2025-06-05	Houghton Michael	Director	Attribution de RSU	3,500	$15.81	$55.34K
2025-06-05	Johnson-pratt Lisa	Director	Attribution de RSU	3,500	$15.81	$55.34K
2025-06-05	Mchutchison John G	Director	Attribution de RSU	3,500	$15.81	$55.34K
2025-06-05	Consylman Gina	Director	Attribution de RSU	3,500	$15.81	$55.34K
2025-06-05	Mahony Susan	Director	Attribution de RSU	3,500	$15.81	$55.34K
2025-06-05	Ringo William R	Director	Attribution de RSU	3,500	$15.81	$55.34K
2025-06-05	Altig Anthony E	Director	Attribution de RSU	3,500	$15.81	$55.34K
2025-03-31	Mchutchison John G	Director	Vente Informative	757	$9.85	$7.46K